nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—XDH—Carboplatin—bone cancer	0.274	0.377	CbGbCtD
Trifluoperazine—XDH—Cisplatin—bone cancer	0.234	0.322	CbGbCtD
Trifluoperazine—XDH—Doxorubicin—bone cancer	0.157	0.216	CbGbCtD
Trifluoperazine—Carpo-pedal spasm—Cisplatin—bone cancer	0.0399	0.306	CcSEcCtD
Trifluoperazine—ABCB1—Cisplatin—bone cancer	0.0267	0.0367	CbGbCtD
Trifluoperazine—ABCB1—Doxorubicin—bone cancer	0.0179	0.0246	CbGbCtD
Trifluoperazine—ABCB1—Methotrexate—bone cancer	0.0173	0.0238	CbGbCtD
Trifluoperazine—Megacolon—Methotrexate—bone cancer	0.00461	0.0355	CcSEcCtD
Trifluoperazine—Tetany—Cisplatin—bone cancer	0.00423	0.0325	CcSEcCtD
Trifluoperazine—CALM1—trigeminal nerve—bone cancer	0.00358	0.102	CbGeAlD
Trifluoperazine—HRH1—nose—bone cancer	0.00333	0.0953	CbGeAlD
Trifluoperazine—CALM1—cranial nerve—bone cancer	0.00255	0.073	CbGeAlD
Trifluoperazine—HTR2A—trigeminal nerve—bone cancer	0.00218	0.0624	CbGeAlD
Trifluoperazine—Pigmentation disorder—Epirubicin—bone cancer	0.00212	0.0163	CcSEcCtD
Trifluoperazine—Retinal disorder—Methotrexate—bone cancer	0.00212	0.0163	CcSEcCtD
Trifluoperazine—Pigmentation disorder—Doxorubicin—bone cancer	0.00196	0.0151	CcSEcCtD
Trifluoperazine—S100A4—connective tissue—bone cancer	0.00184	0.0526	CbGeAlD
Trifluoperazine—Liver injury—Cisplatin—bone cancer	0.00164	0.0126	CcSEcCtD
Trifluoperazine—HTR2A—cranial nerve—bone cancer	0.00155	0.0445	CbGeAlD
Trifluoperazine—TNNC1—connective tissue—bone cancer	0.00155	0.0443	CbGeAlD
Trifluoperazine—HTR2A—vertebral column—bone cancer	0.00152	0.0436	CbGeAlD
Trifluoperazine—Sudden death—Methotrexate—bone cancer	0.00148	0.0114	CcSEcCtD
Trifluoperazine—CALY—spinal cord—bone cancer	0.00141	0.0404	CbGeAlD
Trifluoperazine—Hepatocellular injury—Cisplatin—bone cancer	0.00138	0.0106	CcSEcCtD
Trifluoperazine—Body temperature increased—Carboplatin—bone cancer	0.00133	0.0102	CcSEcCtD
Trifluoperazine—HTR2A—hindlimb—bone cancer	0.00131	0.0375	CbGeAlD
Trifluoperazine—S100A4—tendon—bone cancer	0.00126	0.0362	CbGeAlD
Trifluoperazine—Antrafenine—PTGS2—bone cancer	0.00123	0.22	CrCbGaD
Trifluoperazine—S100A4—bone marrow—bone cancer	0.00122	0.035	CbGeAlD
Trifluoperazine—S100A4—spinal cord—bone cancer	0.00122	0.0349	CbGeAlD
Trifluoperazine—HTR2A—appendage—bone cancer	0.00112	0.0322	CbGeAlD
Trifluoperazine—Haemolytic anaemia—Cisplatin—bone cancer	0.00111	0.00853	CcSEcCtD
Trifluoperazine—Nasal congestion—Cisplatin—bone cancer	0.0011	0.00845	CcSEcCtD
Trifluoperazine—TNNC1—tendon—bone cancer	0.00106	0.0304	CbGeAlD
Trifluoperazine—Anaphylactoid reaction—Cisplatin—bone cancer	0.00104	0.00795	CcSEcCtD
Trifluoperazine—Ileus—Epirubicin—bone cancer	0.001	0.00769	CcSEcCtD
Trifluoperazine—Ventricular arrhythmia—Epirubicin—bone cancer	0.000958	0.00736	CcSEcCtD
Trifluoperazine—Ileus—Doxorubicin—bone cancer	0.000927	0.00712	CcSEcCtD
Trifluoperazine—Ventricular arrhythmia—Doxorubicin—bone cancer	0.000886	0.00681	CcSEcCtD
Trifluoperazine—Glycosuria—Epirubicin—bone cancer	0.000875	0.00672	CcSEcCtD
Trifluoperazine—Blood disorder—Epirubicin—bone cancer	0.000849	0.00652	CcSEcCtD
Trifluoperazine—Liver injury—Epirubicin—bone cancer	0.000842	0.00647	CcSEcCtD
Trifluoperazine—Pancytopenia—Cisplatin—bone cancer	0.000822	0.00632	CcSEcCtD
Trifluoperazine—Glycosuria—Doxorubicin—bone cancer	0.00081	0.00622	CcSEcCtD
Trifluoperazine—Amenorrhoea—Epirubicin—bone cancer	0.000807	0.0062	CcSEcCtD
Trifluoperazine—Clomipramine—GSTP1—bone cancer	0.000787	0.141	CrCbGaD
Trifluoperazine—Blood disorder—Doxorubicin—bone cancer	0.000785	0.00603	CcSEcCtD
Trifluoperazine—Liver injury—Doxorubicin—bone cancer	0.000779	0.00599	CcSEcCtD
Trifluoperazine—Dyskinesia—Epirubicin—bone cancer	0.000754	0.0058	CcSEcCtD
Trifluoperazine—Amenorrhoea—Doxorubicin—bone cancer	0.000746	0.00574	CcSEcCtD
Trifluoperazine—Gait disturbance—Epirubicin—bone cancer	0.000726	0.00558	CcSEcCtD
Trifluoperazine—Aplastic anaemia—Methotrexate—bone cancer	0.000711	0.00546	CcSEcCtD
Trifluoperazine—Hepatocellular injury—Epirubicin—bone cancer	0.000709	0.00545	CcSEcCtD
Trifluoperazine—Dyskinesia—Doxorubicin—bone cancer	0.000698	0.00536	CcSEcCtD
Trifluoperazine—Gynaecomastia—Methotrexate—bone cancer	0.000678	0.00521	CcSEcCtD
Trifluoperazine—Gait disturbance—Doxorubicin—bone cancer	0.000672	0.00516	CcSEcCtD
Trifluoperazine—Aplastic anaemia—Epirubicin—bone cancer	0.000665	0.00511	CcSEcCtD
Trifluoperazine—Hepatocellular injury—Doxorubicin—bone cancer	0.000656	0.00504	CcSEcCtD
Trifluoperazine—Photosensitivity—Methotrexate—bone cancer	0.000626	0.00481	CcSEcCtD
Trifluoperazine—Aplastic anaemia—Doxorubicin—bone cancer	0.000616	0.00473	CcSEcCtD
Trifluoperazine—Erythema—Cisplatin—bone cancer	0.000603	0.00464	CcSEcCtD
Trifluoperazine—Photosensitivity—Epirubicin—bone cancer	0.000586	0.0045	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Methotrexate—bone cancer	0.000583	0.00448	CcSEcCtD
Trifluoperazine—Muscle spasms—Cisplatin—bone cancer	0.00058	0.00446	CcSEcCtD
Trifluoperazine—Eczema—Epirubicin—bone cancer	0.000573	0.0044	CcSEcCtD
Trifluoperazine—Vision blurred—Cisplatin—bone cancer	0.000569	0.00437	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Methotrexate—bone cancer	0.000568	0.00436	CcSEcCtD
Trifluoperazine—Tremor—Cisplatin—bone cancer	0.000565	0.00434	CcSEcCtD
Trifluoperazine—Increased appetite—Epirubicin—bone cancer	0.000548	0.00421	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Epirubicin—bone cancer	0.000545	0.00419	CcSEcCtD
Trifluoperazine—Photosensitivity—Doxorubicin—bone cancer	0.000542	0.00417	CcSEcCtD
Trifluoperazine—Leukopenia—Cisplatin—bone cancer	0.00054	0.00415	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Epirubicin—bone cancer	0.000532	0.00408	CcSEcCtD
Trifluoperazine—Eczema—Doxorubicin—bone cancer	0.00053	0.00407	CcSEcCtD
Trifluoperazine—CALM2—connective tissue—bone cancer	0.000529	0.0151	CbGeAlD
Trifluoperazine—Hypoglycaemia—Epirubicin—bone cancer	0.000527	0.00405	CcSEcCtD
Trifluoperazine—CALM1—connective tissue—bone cancer	0.000526	0.0151	CbGeAlD
Trifluoperazine—Alimemazine—CYP3A4—bone cancer	0.000526	0.0941	CrCbGaD
Trifluoperazine—Convulsion—Cisplatin—bone cancer	0.000523	0.00402	CcSEcCtD
Trifluoperazine—Increased appetite—Doxorubicin—bone cancer	0.000507	0.00389	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000505	0.00388	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Cisplatin—bone cancer	0.000492	0.00378	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000492	0.00378	CcSEcCtD
Trifluoperazine—Cardiac arrest—Epirubicin—bone cancer	0.000489	0.00376	CcSEcCtD
Trifluoperazine—Hypoglycaemia—Doxorubicin—bone cancer	0.000488	0.00375	CcSEcCtD
Trifluoperazine—Skin disorder—Cisplatin—bone cancer	0.000478	0.00368	CcSEcCtD
Trifluoperazine—Asthma—Methotrexate—bone cancer	0.000475	0.00365	CcSEcCtD
Trifluoperazine—Eosinophilia—Methotrexate—bone cancer	0.00047	0.00362	CcSEcCtD
Trifluoperazine—Anorexia—Cisplatin—bone cancer	0.000469	0.00361	CcSEcCtD
Trifluoperazine—CALM3—tendon—bone cancer	0.000463	0.0133	CbGeAlD
Trifluoperazine—Hypotension—Cisplatin—bone cancer	0.00046	0.00354	CcSEcCtD
Trifluoperazine—Muscular weakness—Epirubicin—bone cancer	0.000454	0.00349	CcSEcCtD
Trifluoperazine—Cardiac arrest—Doxorubicin—bone cancer	0.000453	0.00348	CcSEcCtD
Trifluoperazine—Mequitazine—CYP3A4—bone cancer	0.000452	0.081	CrCbGaD
Trifluoperazine—Pancytopenia—Methotrexate—bone cancer	0.000451	0.00347	CcSEcCtD
Trifluoperazine—CALM3—bone marrow—bone cancer	0.000448	0.0128	CbGeAlD
Trifluoperazine—CALM3—spinal cord—bone cancer	0.000446	0.0128	CbGeAlD
Trifluoperazine—Asthma—Epirubicin—bone cancer	0.000445	0.00342	CcSEcCtD
Trifluoperazine—Dysphagia—Epirubicin—bone cancer	0.000445	0.00342	CcSEcCtD
Trifluoperazine—Eosinophilia—Epirubicin—bone cancer	0.00044	0.00338	CcSEcCtD
Trifluoperazine—Dyspnoea—Cisplatin—bone cancer	0.000439	0.00337	CcSEcCtD
Trifluoperazine—Erectile dysfunction—Methotrexate—bone cancer	0.000438	0.00336	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Methotrexate—bone cancer	0.000434	0.00333	CcSEcCtD
Trifluoperazine—Decreased appetite—Cisplatin—bone cancer	0.000428	0.00329	CcSEcCtD
Trifluoperazine—Drowsiness—Methotrexate—bone cancer	0.000424	0.00326	CcSEcCtD
Trifluoperazine—HTR2C—spinal cord—bone cancer	0.000424	0.0121	CbGeAlD
Trifluoperazine—Pancytopenia—Epirubicin—bone cancer	0.000422	0.00324	CcSEcCtD
Trifluoperazine—Muscular weakness—Doxorubicin—bone cancer	0.00042	0.00323	CcSEcCtD
Trifluoperazine—SIGMAR1—tendon—bone cancer	0.000414	0.0118	CbGeAlD
Trifluoperazine—Asthma—Doxorubicin—bone cancer	0.000411	0.00316	CcSEcCtD
Trifluoperazine—Dysphagia—Doxorubicin—bone cancer	0.000411	0.00316	CcSEcCtD
Trifluoperazine—Eosinophilia—Doxorubicin—bone cancer	0.000407	0.00313	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Epirubicin—bone cancer	0.000406	0.00312	CcSEcCtD
Trifluoperazine—Weight increased—Epirubicin—bone cancer	0.000405	0.00311	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Epirubicin—bone cancer	0.000401	0.00308	CcSEcCtD
Trifluoperazine—SIGMAR1—bone marrow—bone cancer	0.000401	0.0115	CbGeAlD
Trifluoperazine—SIGMAR1—spinal cord—bone cancer	0.000399	0.0114	CbGeAlD
Trifluoperazine—Drowsiness—Epirubicin—bone cancer	0.000396	0.00305	CcSEcCtD
Trifluoperazine—Agranulocytosis—Methotrexate—bone cancer	0.000395	0.00304	CcSEcCtD
Trifluoperazine—Pancytopenia—Doxorubicin—bone cancer	0.000391	0.003	CcSEcCtD
Trifluoperazine—Body temperature increased—Cisplatin—bone cancer	0.000389	0.00299	CcSEcCtD
Trifluoperazine—Jaundice—Epirubicin—bone cancer	0.000386	0.00297	CcSEcCtD
Trifluoperazine—HRH1—connective tissue—bone cancer	0.000384	0.011	CbGeAlD
Trifluoperazine—Photosensitivity reaction—Doxorubicin—bone cancer	0.000376	0.00289	CcSEcCtD
Trifluoperazine—Weight increased—Doxorubicin—bone cancer	0.000374	0.00288	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Doxorubicin—bone cancer	0.000371	0.00285	CcSEcCtD
Trifluoperazine—Nefazodone—CYP3A4—bone cancer	0.000371	0.0665	CrCbGaD
Trifluoperazine—Agranulocytosis—Epirubicin—bone cancer	0.00037	0.00284	CcSEcCtD
Trifluoperazine—Drowsiness—Doxorubicin—bone cancer	0.000367	0.00282	CcSEcCtD
Trifluoperazine—CALM2—tendon—bone cancer	0.000363	0.0104	CbGeAlD
Trifluoperazine—Hypersensitivity—Cisplatin—bone cancer	0.000363	0.00279	CcSEcCtD
Trifluoperazine—CALM1—tendon—bone cancer	0.000362	0.0104	CbGeAlD
Trifluoperazine—Jaundice—Doxorubicin—bone cancer	0.000358	0.00275	CcSEcCtD
Trifluoperazine—HTR1A—spinal cord—bone cancer	0.000357	0.0102	CbGeAlD
Trifluoperazine—Asthenia—Cisplatin—bone cancer	0.000353	0.00271	CcSEcCtD
Trifluoperazine—CALM2—bone marrow—bone cancer	0.000352	0.0101	CbGeAlD
Trifluoperazine—Oedema peripheral—Epirubicin—bone cancer	0.000351	0.00269	CcSEcCtD
Trifluoperazine—CALM2—spinal cord—bone cancer	0.00035	0.01	CbGeAlD
Trifluoperazine—CALM1—bone marrow—bone cancer	0.00035	0.01	CbGeAlD
Trifluoperazine—CALM1—spinal cord—bone cancer	0.000349	0.00999	CbGeAlD
Trifluoperazine—Trazodone—CYP3A4—bone cancer	0.000343	0.0615	CrCbGaD
Trifluoperazine—Agranulocytosis—Doxorubicin—bone cancer	0.000342	0.00263	CcSEcCtD
Trifluoperazine—Erythema—Methotrexate—bone cancer	0.000331	0.00254	CcSEcCtD
Trifluoperazine—Oedema peripheral—Doxorubicin—bone cancer	0.000324	0.00249	CcSEcCtD
Trifluoperazine—Pipotiazine—CYP3A4—bone cancer	0.000322	0.0576	CrCbGaD
Trifluoperazine—HTR2A—connective tissue—bone cancer	0.000321	0.00918	CbGeAlD
Trifluoperazine—Vision blurred—Methotrexate—bone cancer	0.000312	0.0024	CcSEcCtD
Trifluoperazine—Rash—Cisplatin—bone cancer	0.00031	0.00239	CcSEcCtD
Trifluoperazine—Dermatitis—Cisplatin—bone cancer	0.00031	0.00238	CcSEcCtD
Trifluoperazine—Erythema—Epirubicin—bone cancer	0.00031	0.00238	CcSEcCtD
Trifluoperazine—Prochlorperazine—CYP3A4—bone cancer	0.000308	0.0551	CrCbGaD
Trifluoperazine—Nervousness—Epirubicin—bone cancer	0.000301	0.00231	CcSEcCtD
Trifluoperazine—Muscle spasms—Epirubicin—bone cancer	0.000298	0.00229	CcSEcCtD
Trifluoperazine—Leukopenia—Methotrexate—bone cancer	0.000296	0.00228	CcSEcCtD
Trifluoperazine—Nausea—Cisplatin—bone cancer	0.000292	0.00225	CcSEcCtD
Trifluoperazine—Vision blurred—Epirubicin—bone cancer	0.000292	0.00224	CcSEcCtD
Trifluoperazine—Cough—Methotrexate—bone cancer	0.000289	0.00222	CcSEcCtD
Trifluoperazine—Convulsion—Methotrexate—bone cancer	0.000287	0.0022	CcSEcCtD
Trifluoperazine—Erythema—Doxorubicin—bone cancer	0.000287	0.0022	CcSEcCtD
Trifluoperazine—Agitation—Epirubicin—bone cancer	0.000285	0.00219	CcSEcCtD
Trifluoperazine—Nervousness—Doxorubicin—bone cancer	0.000278	0.00214	CcSEcCtD
Trifluoperazine—Leukopenia—Epirubicin—bone cancer	0.000277	0.00213	CcSEcCtD
Trifluoperazine—Muscle spasms—Doxorubicin—bone cancer	0.000276	0.00212	CcSEcCtD
Trifluoperazine—Cough—Epirubicin—bone cancer	0.00027	0.00208	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Methotrexate—bone cancer	0.00027	0.00208	CcSEcCtD
Trifluoperazine—Vision blurred—Doxorubicin—bone cancer	0.00027	0.00208	CcSEcCtD
Trifluoperazine—Convulsion—Epirubicin—bone cancer	0.000268	0.00206	CcSEcCtD
Trifluoperazine—HRH1—tendon—bone cancer	0.000264	0.00756	CbGeAlD
Trifluoperazine—Agitation—Doxorubicin—bone cancer	0.000263	0.00202	CcSEcCtD
Trifluoperazine—Skin disorder—Methotrexate—bone cancer	0.000262	0.00202	CcSEcCtD
Trifluoperazine—Dry mouth—Epirubicin—bone cancer	0.000258	0.00198	CcSEcCtD
Trifluoperazine—Anorexia—Methotrexate—bone cancer	0.000258	0.00198	CcSEcCtD
Trifluoperazine—Leukopenia—Doxorubicin—bone cancer	0.000257	0.00197	CcSEcCtD
Trifluoperazine—Clomipramine—CYP3A4—bone cancer	0.000254	0.0455	CrCbGaD
Trifluoperazine—Anaphylactic shock—Epirubicin—bone cancer	0.000253	0.00194	CcSEcCtD
Trifluoperazine—Hypotension—Methotrexate—bone cancer	0.000253	0.00194	CcSEcCtD
Trifluoperazine—Cough—Doxorubicin—bone cancer	0.00025	0.00192	CcSEcCtD
Trifluoperazine—Convulsion—Doxorubicin—bone cancer	0.000248	0.00191	CcSEcCtD
Trifluoperazine—Skin disorder—Epirubicin—bone cancer	0.000246	0.00189	CcSEcCtD
Trifluoperazine—Insomnia—Methotrexate—bone cancer	0.000244	0.00188	CcSEcCtD
Trifluoperazine—Anorexia—Epirubicin—bone cancer	0.000241	0.00185	CcSEcCtD
Trifluoperazine—Dyspnoea—Methotrexate—bone cancer	0.000241	0.00185	CcSEcCtD
Trifluoperazine—Somnolence—Methotrexate—bone cancer	0.00024	0.00185	CcSEcCtD
Trifluoperazine—Dry mouth—Doxorubicin—bone cancer	0.000239	0.00183	CcSEcCtD
Trifluoperazine—Hypotension—Epirubicin—bone cancer	0.000236	0.00182	CcSEcCtD
Trifluoperazine—Decreased appetite—Methotrexate—bone cancer	0.000235	0.0018	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Doxorubicin—bone cancer	0.000234	0.0018	CcSEcCtD
Trifluoperazine—Fatigue—Methotrexate—bone cancer	0.000233	0.00179	CcSEcCtD
Trifluoperazine—Insomnia—Epirubicin—bone cancer	0.000229	0.00176	CcSEcCtD
Trifluoperazine—Skin disorder—Doxorubicin—bone cancer	0.000227	0.00175	CcSEcCtD
Trifluoperazine—Dyspnoea—Epirubicin—bone cancer	0.000225	0.00173	CcSEcCtD
Trifluoperazine—Somnolence—Epirubicin—bone cancer	0.000225	0.00173	CcSEcCtD
Trifluoperazine—Anorexia—Doxorubicin—bone cancer	0.000223	0.00171	CcSEcCtD
Trifluoperazine—HTR2A—tendon—bone cancer	0.00022	0.00631	CbGeAlD
Trifluoperazine—Perphenazine—CYP3A4—bone cancer	0.00022	0.0394	CrCbGaD
Trifluoperazine—Decreased appetite—Epirubicin—bone cancer	0.00022	0.00169	CcSEcCtD
Trifluoperazine—Hypotension—Doxorubicin—bone cancer	0.000219	0.00168	CcSEcCtD
Trifluoperazine—Fatigue—Epirubicin—bone cancer	0.000218	0.00168	CcSEcCtD
Trifluoperazine—Constipation—Epirubicin—bone cancer	0.000216	0.00166	CcSEcCtD
Trifluoperazine—Quetiapine—CYP3A4—bone cancer	0.000216	0.0386	CrCbGaD
Trifluoperazine—Urticaria—Methotrexate—bone cancer	0.000215	0.00165	CcSEcCtD
Trifluoperazine—Body temperature increased—Methotrexate—bone cancer	0.000214	0.00164	CcSEcCtD
Trifluoperazine—HTR2A—spinal cord—bone cancer	0.000212	0.00609	CbGeAlD
Trifluoperazine—Insomnia—Doxorubicin—bone cancer	0.000212	0.00163	CcSEcCtD
Trifluoperazine—Dyspnoea—Doxorubicin—bone cancer	0.000209	0.0016	CcSEcCtD
Trifluoperazine—Somnolence—Doxorubicin—bone cancer	0.000208	0.0016	CcSEcCtD
Trifluoperazine—Decreased appetite—Doxorubicin—bone cancer	0.000203	0.00156	CcSEcCtD
Trifluoperazine—Fatigue—Doxorubicin—bone cancer	0.000202	0.00155	CcSEcCtD
Trifluoperazine—Urticaria—Epirubicin—bone cancer	0.000201	0.00154	CcSEcCtD
Trifluoperazine—Constipation—Doxorubicin—bone cancer	0.0002	0.00154	CcSEcCtD
Trifluoperazine—Body temperature increased—Epirubicin—bone cancer	0.0002	0.00154	CcSEcCtD
Trifluoperazine—Hypersensitivity—Methotrexate—bone cancer	0.000199	0.00153	CcSEcCtD
Trifluoperazine—Promazine—CYP3A4—bone cancer	0.000198	0.0355	CrCbGaD
Trifluoperazine—Asthenia—Methotrexate—bone cancer	0.000194	0.00149	CcSEcCtD
Trifluoperazine—Pruritus—Methotrexate—bone cancer	0.000191	0.00147	CcSEcCtD
Trifluoperazine—Hypersensitivity—Epirubicin—bone cancer	0.000186	0.00143	CcSEcCtD
Trifluoperazine—Urticaria—Doxorubicin—bone cancer	0.000186	0.00143	CcSEcCtD
Trifluoperazine—Clozapine—CYP3A4—bone cancer	0.000185	0.0332	CrCbGaD
Trifluoperazine—Body temperature increased—Doxorubicin—bone cancer	0.000185	0.00142	CcSEcCtD
Trifluoperazine—Asthenia—Epirubicin—bone cancer	0.000181	0.00139	CcSEcCtD
Trifluoperazine—Pruritus—Epirubicin—bone cancer	0.000179	0.00137	CcSEcCtD
Trifluoperazine—Dizziness—Methotrexate—bone cancer	0.000179	0.00137	CcSEcCtD
Trifluoperazine—Chlorpromazine—CYP3A4—bone cancer	0.000174	0.0312	CrCbGaD
Trifluoperazine—Hypersensitivity—Doxorubicin—bone cancer	0.000172	0.00132	CcSEcCtD
Trifluoperazine—Rash—Methotrexate—bone cancer	0.00017	0.00131	CcSEcCtD
Trifluoperazine—Dermatitis—Methotrexate—bone cancer	0.00017	0.00131	CcSEcCtD
Trifluoperazine—Headache—Methotrexate—bone cancer	0.000169	0.0013	CcSEcCtD
Trifluoperazine—Asthenia—Doxorubicin—bone cancer	0.000168	0.00129	CcSEcCtD
Trifluoperazine—Dizziness—Epirubicin—bone cancer	0.000167	0.00128	CcSEcCtD
Trifluoperazine—Pruritus—Doxorubicin—bone cancer	0.000166	0.00127	CcSEcCtD
Trifluoperazine—Nausea—Methotrexate—bone cancer	0.000161	0.00123	CcSEcCtD
Trifluoperazine—Rash—Epirubicin—bone cancer	0.000159	0.00123	CcSEcCtD
Trifluoperazine—Dermatitis—Epirubicin—bone cancer	0.000159	0.00122	CcSEcCtD
Trifluoperazine—Headache—Epirubicin—bone cancer	0.000158	0.00122	CcSEcCtD
Trifluoperazine—Dizziness—Doxorubicin—bone cancer	0.000155	0.00119	CcSEcCtD
Trifluoperazine—Nausea—Epirubicin—bone cancer	0.00015	0.00115	CcSEcCtD
Trifluoperazine—Rash—Doxorubicin—bone cancer	0.000148	0.00113	CcSEcCtD
Trifluoperazine—Dermatitis—Doxorubicin—bone cancer	0.000147	0.00113	CcSEcCtD
Trifluoperazine—Headache—Doxorubicin—bone cancer	0.000147	0.00113	CcSEcCtD
Trifluoperazine—ABCB1—bone marrow—bone cancer	0.00014	0.00401	CbGeAlD
Trifluoperazine—ABCB1—spinal cord—bone cancer	0.000139	0.00399	CbGeAlD
Trifluoperazine—Nausea—Doxorubicin—bone cancer	0.000139	0.00107	CcSEcCtD
Trifluoperazine—CALM2—Signaling by GPCR—IL3—bone cancer	3.06e-05	0.000298	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL3—bone cancer	3.06e-05	0.000298	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—DHFR—bone cancer	3.05e-05	0.000297	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—DHFR—bone cancer	3.05e-05	0.000297	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TGFBR2—bone cancer	3.01e-05	0.000294	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—ATF1—bone cancer	2.96e-05	0.000289	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—KIT—bone cancer	2.9e-05	0.000282	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL3—bone cancer	2.89e-05	0.000282	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—GNA11—bone cancer	2.87e-05	0.00028	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—ATF1—bone cancer	2.87e-05	0.00028	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—ATF1—bone cancer	2.87e-05	0.00028	CbGpPWpGaD
Trifluoperazine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.86e-05	0.000279	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—GNA11—bone cancer	2.86e-05	0.000279	CbGpPWpGaD
Trifluoperazine—XDH—Metabolism—PTGS2—bone cancer	2.85e-05	0.000278	CbGpPWpGaD
Trifluoperazine—UGT1A4—Metabolism—PTGS2—bone cancer	2.85e-05	0.000278	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—ENO2—bone cancer	2.84e-05	0.000277	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IGF1R—bone cancer	2.83e-05	0.000276	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—KIT—bone cancer	2.8e-05	0.000273	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—KIT—bone cancer	2.8e-05	0.000273	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL3—bone cancer	2.8e-05	0.000273	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL3—bone cancer	2.8e-05	0.000273	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—KIT—bone cancer	2.78e-05	0.000271	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—SMO—bone cancer	2.76e-05	0.000269	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—ENO2—bone cancer	2.75e-05	0.000268	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—ENO2—bone cancer	2.75e-05	0.000268	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by NGF—EGFR—bone cancer	2.73e-05	0.000266	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—SMO—bone cancer	2.71e-05	0.000265	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—SMO—bone cancer	2.71e-05	0.000264	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—KIT—bone cancer	2.69e-05	0.000262	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—KIT—bone cancer	2.69e-05	0.000262	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—ATF1—bone cancer	2.67e-05	0.000261	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—SMO—bone cancer	2.66e-05	0.00026	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—ATF1—bone cancer	2.66e-05	0.000259	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—SMO—bone cancer	2.66e-05	0.000259	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by NGF—EGFR—bone cancer	2.64e-05	0.000258	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by NGF—EGFR—bone cancer	2.64e-05	0.000258	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—DHFR—bone cancer	2.64e-05	0.000257	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL3—bone cancer	2.61e-05	0.000254	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL3—bone cancer	2.59e-05	0.000253	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—DHFR—bone cancer	2.55e-05	0.000249	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—DHFR—bone cancer	2.55e-05	0.000249	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—GNA11—bone cancer	2.52e-05	0.000246	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—GNA11—bone cancer	2.48e-05	0.000242	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—GNA11—bone cancer	2.48e-05	0.000242	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—GNA11—bone cancer	2.46e-05	0.00024	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—GNA11—bone cancer	2.44e-05	0.000238	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—GNA11—bone cancer	2.43e-05	0.000237	CbGpPWpGaD
Trifluoperazine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.4e-05	0.000234	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—GNA11—bone cancer	2.38e-05	0.000233	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—GNA11—bone cancer	2.38e-05	0.000233	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—ATF1—bone cancer	2.35e-05	0.000229	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—ATF1—bone cancer	2.31e-05	0.000225	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—ATF1—bone cancer	2.3e-05	0.000225	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL3—bone cancer	2.29e-05	0.000223	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—TGFBR2—bone cancer	2.28e-05	0.000223	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—MDM2—bone cancer	2.28e-05	0.000222	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—ATF1—bone cancer	2.27e-05	0.000221	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—ATF1—bone cancer	2.26e-05	0.00022	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—SMO—bone cancer	2.25e-05	0.00022	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL3—bone cancer	2.25e-05	0.00022	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL3—bone cancer	2.25e-05	0.000219	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—CYP3A4—bone cancer	2.23e-05	0.000218	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TGFBR2—bone cancer	2.23e-05	0.000217	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TGFBR2—bone cancer	2.22e-05	0.000216	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL3—bone cancer	2.21e-05	0.000216	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—TGFBR2—bone cancer	2.21e-05	0.000215	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—TGFBR2—bone cancer	2.21e-05	0.000215	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—MDM2—bone cancer	2.21e-05	0.000215	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—MDM2—bone cancer	2.21e-05	0.000215	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL3—bone cancer	2.2e-05	0.000215	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—MDM2—bone cancer	2.19e-05	0.000214	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—SMO—bone cancer	2.18e-05	0.000213	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—SMO—bone cancer	2.18e-05	0.000213	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—CYP3A4—bone cancer	2.16e-05	0.000211	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—CYP3A4—bone cancer	2.16e-05	0.000211	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—ENO2—bone cancer	2.15e-05	0.00021	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—MDM2—bone cancer	2.12e-05	0.000207	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—MDM2—bone cancer	2.12e-05	0.000207	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IGF1R—bone cancer	2.1e-05	0.000204	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IGF1R—bone cancer	2.09e-05	0.000203	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—GNA11—bone cancer	2.06e-05	0.000201	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—KIT—bone cancer	2.05e-05	0.0002	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—DHFR—bone cancer	2e-05	0.000195	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—GNA11—bone cancer	1.99e-05	0.000194	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—GNA11—bone cancer	1.99e-05	0.000194	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—JUN—bone cancer	1.98e-05	0.000193	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TGFBR2—bone cancer	1.96e-05	0.000191	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—BRAF—bone cancer	1.93e-05	0.000188	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TGFBR2—bone cancer	1.92e-05	0.000188	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TGFBR2—bone cancer	1.92e-05	0.000187	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—JUN—bone cancer	1.92e-05	0.000187	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—JUN—bone cancer	1.92e-05	0.000187	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—ATF1—bone cancer	1.92e-05	0.000187	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—GSTP1—bone cancer	1.91e-05	0.000186	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TGFBR2—bone cancer	1.89e-05	0.000184	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	1.88e-05	0.000184	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—EGFR—bone cancer	1.87e-05	0.000183	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL3—bone cancer	1.87e-05	0.000182	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—GNA11—bone cancer	1.87e-05	0.000182	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—ATF1—bone cancer	1.85e-05	0.000181	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—ATF1—bone cancer	1.85e-05	0.000181	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—GSTP1—bone cancer	1.85e-05	0.00018	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—GSTP1—bone cancer	1.85e-05	0.00018	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IGF1R—bone cancer	1.84e-05	0.00018	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IGF1R—bone cancer	1.81e-05	0.000177	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL3—bone cancer	1.81e-05	0.000176	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL3—bone cancer	1.81e-05	0.000176	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IGF1R—bone cancer	1.81e-05	0.000176	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IGF1R—bone cancer	1.78e-05	0.000173	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IGF1R—bone cancer	1.77e-05	0.000173	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ENO2—bone cancer	1.72e-05	0.000168	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—CYP3A4—bone cancer	1.69e-05	0.000165	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—KIT—bone cancer	1.69e-05	0.000164	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—KIT—bone cancer	1.63e-05	0.000159	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—KIT—bone cancer	1.63e-05	0.000159	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—MDM2—bone cancer	1.62e-05	0.000158	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TGFBR2—bone cancer	1.6e-05	0.000156	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—DHFR—bone cancer	1.6e-05	0.000156	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—EGFR—bone cancer	1.56e-05	0.000152	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—KIT—bone cancer	1.56e-05	0.000152	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TGFBR2—bone cancer	1.55e-05	0.000151	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TGFBR2—bone cancer	1.55e-05	0.000151	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—KIT—bone cancer	1.52e-05	0.000148	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—KIT—bone cancer	1.51e-05	0.000148	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—EGFR—bone cancer	1.51e-05	0.000147	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—EGFR—bone cancer	1.51e-05	0.000147	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—KIT—bone cancer	1.51e-05	0.000147	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—KIT—bone cancer	1.51e-05	0.000147	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IGF1R—bone cancer	1.5e-05	0.000147	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—EGFR—bone cancer	1.5e-05	0.000146	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GNA11—bone cancer	1.49e-05	0.000145	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—BRAF—bone cancer	1.46e-05	0.000143	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IGF1R—bone cancer	1.45e-05	0.000142	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IGF1R—bone cancer	1.45e-05	0.000142	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—TP53—bone cancer	1.45e-05	0.000142	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—GSTP1—bone cancer	1.45e-05	0.000141	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—EGFR—bone cancer	1.45e-05	0.000141	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—EGFR—bone cancer	1.45e-05	0.000141	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—BRAF—bone cancer	1.43e-05	0.000139	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—BRAF—bone cancer	1.42e-05	0.000139	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—BRAF—bone cancer	1.42e-05	0.000138	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—BRAF—bone cancer	1.42e-05	0.000138	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—JUN—bone cancer	1.41e-05	0.000137	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—TP53—bone cancer	1.41e-05	0.000137	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—TP53—bone cancer	1.41e-05	0.000137	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.39e-05	0.000135	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—EGFR—bone cancer	1.38e-05	0.000134	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—MMP9—bone cancer	1.37e-05	0.000133	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CYP3A4—bone cancer	1.35e-05	0.000132	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.34e-05	0.000131	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—KIT—bone cancer	1.33e-05	0.00013	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—MDM2—bone cancer	1.33e-05	0.00013	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—KIT—bone cancer	1.31e-05	0.000128	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—KIT—bone cancer	1.31e-05	0.000128	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—KIT—bone cancer	1.29e-05	0.000126	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—KIT—bone cancer	1.29e-05	0.000125	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—MDM2—bone cancer	1.28e-05	0.000125	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—MDM2—bone cancer	1.28e-05	0.000125	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—BRAF—bone cancer	1.25e-05	0.000122	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—BRAF—bone cancer	1.23e-05	0.00012	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—BRAF—bone cancer	1.23e-05	0.00012	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—MDM2—bone cancer	1.23e-05	0.00012	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—EGFR—bone cancer	1.22e-05	0.000119	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—BRAF—bone cancer	1.21e-05	0.000118	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—BRAF—bone cancer	1.21e-05	0.000118	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MDM2—bone cancer	1.2e-05	0.000117	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—EGFR—bone cancer	1.2e-05	0.000117	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—EGFR—bone cancer	1.19e-05	0.000116	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MDM2—bone cancer	1.19e-05	0.000116	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MDM2—bone cancer	1.19e-05	0.000116	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MDM2—bone cancer	1.19e-05	0.000116	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PTGS2—bone cancer	1.18e-05	0.000115	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—EGFR—bone cancer	1.17e-05	0.000115	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—EGFR—bone cancer	1.17e-05	0.000114	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GSTP1—bone cancer	1.16e-05	0.000113	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—JUN—bone cancer	1.15e-05	0.000113	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PTGS2—bone cancer	1.14e-05	0.000112	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PTGS2—bone cancer	1.14e-05	0.000112	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—JUN—bone cancer	1.12e-05	0.000109	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—JUN—bone cancer	1.12e-05	0.000109	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—EGFR—bone cancer	1.11e-05	0.000108	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—KIT—bone cancer	1.09e-05	0.000106	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—KIT—bone cancer	1.05e-05	0.000103	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—KIT—bone cancer	1.05e-05	0.000103	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MDM2—bone cancer	1.05e-05	0.000103	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—JUN—bone cancer	1.04e-05	0.000102	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—JUN—bone cancer	1.04e-05	0.000101	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MDM2—bone cancer	1.03e-05	0.000101	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MDM2—bone cancer	1.03e-05	0.000101	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—BRAF—bone cancer	1.02e-05	0.0001	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MDM2—bone cancer	1.02e-05	9.91e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MDM2—bone cancer	1.01e-05	9.88e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MMP9—bone cancer	1.01e-05	9.88e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MMP9—bone cancer	1.01e-05	9.83e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—EGFR—bone cancer	9.93e-06	9.69e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—BRAF—bone cancer	9.91e-06	9.67e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—BRAF—bone cancer	9.91e-06	9.67e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PTGS2—bone cancer	9.9e-06	9.66e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—EGFR—bone cancer	9.61e-06	9.37e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—EGFR—bone cancer	9.61e-06	9.37e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PTGS2—bone cancer	9.58e-06	9.34e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PTGS2—bone cancer	9.58e-06	9.34e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TP53—bone cancer	9.28e-06	9.05e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—JUN—bone cancer	9.14e-06	8.91e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—EGFR—bone cancer	9.08e-06	8.85e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—JUN—bone cancer	8.99e-06	8.77e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—JUN—bone cancer	8.97e-06	8.75e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MMP9—bone cancer	8.89e-06	8.67e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—JUN—bone cancer	8.83e-06	8.61e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—JUN—bone cancer	8.8e-06	8.59e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—EGFR—bone cancer	8.78e-06	8.56e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—EGFR—bone cancer	8.78e-06	8.56e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MMP9—bone cancer	8.75e-06	8.53e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MMP9—bone cancer	8.73e-06	8.51e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MMP9—bone cancer	8.59e-06	8.38e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MDM2—bone cancer	8.59e-06	8.37e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MMP9—bone cancer	8.57e-06	8.35e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—EGFR—bone cancer	8.38e-06	8.17e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MDM2—bone cancer	8.31e-06	8.1e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MDM2—bone cancer	8.31e-06	8.1e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—EGFR—bone cancer	8.18e-06	7.98e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—EGFR—bone cancer	8.14e-06	7.94e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—EGFR—bone cancer	8.11e-06	7.91e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—EGFR—bone cancer	8.11e-06	7.91e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTGS2—bone cancer	7.5e-06	7.32e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—JUN—bone cancer	7.46e-06	7.28e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MMP9—bone cancer	7.26e-06	7.08e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—JUN—bone cancer	7.22e-06	7.04e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—JUN—bone cancer	7.22e-06	7.04e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EGFR—bone cancer	7.18e-06	7.01e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EGFR—bone cancer	7.07e-06	6.89e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EGFR—bone cancer	7.05e-06	6.88e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MMP9—bone cancer	7.02e-06	6.85e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MMP9—bone cancer	7.02e-06	6.85e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EGFR—bone cancer	6.94e-06	6.77e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EGFR—bone cancer	6.92e-06	6.75e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TP53—bone cancer	6.87e-06	6.7e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TP53—bone cancer	6.83e-06	6.67e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TP53—bone cancer	6.03e-06	5.88e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTGS2—bone cancer	5.99e-06	5.84e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TP53—bone cancer	5.94e-06	5.79e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TP53—bone cancer	5.92e-06	5.78e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EGFR—bone cancer	5.87e-06	5.72e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TP53—bone cancer	5.83e-06	5.68e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TP53—bone cancer	5.81e-06	5.67e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EGFR—bone cancer	5.68e-06	5.54e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EGFR—bone cancer	5.68e-06	5.54e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TP53—bone cancer	4.93e-06	4.81e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TP53—bone cancer	4.77e-06	4.65e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TP53—bone cancer	4.77e-06	4.65e-05	CbGpPWpGaD
